Breast Cancer Episode 17: Insights from the KATHERINE Trial: iDFS surrogate endpoint is predictive for OS in breast cancer patients 29 February 2024
GI Episode 8: Neo-adjuvant immunotherapy and pCR as a biomarker in G/GEJ cancer: insights from the KEYNOTE-585 + MATTERHORN study 28 February 2024
Lung Cancer Episode 5: KEYNOTE-671 demonstrates the OS benefit of perioperative immunochemotherapy in early-stage NSCLC 27 February 2024
Breast Cancer Episode 16: The NATALEE trial: ribociclib as a key adjuvant CDK4/6 Inhibitor for breast cancer 22 February 2024
Breast Cancer Episode 15: 5-Year Follow-Up of Abemaciclib Plus Endocrine Therapy in High-Risk HR+/HER2- Early Breast Cancer – Insights from the MonarchE Study 15 February 2024
GI Episode 6: Fruquintinib, a new drug in refractory, metastatic colorectal cancer: results from the FRESCO-2 trial 14 February 2024
